Viewing Study NCT01689259


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-04-15 @ 3:12 PM
Study NCT ID: NCT01689259
Status: COMPLETED
Last Update Posted: 2014-09-26
First Post: 2012-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults
Sponsor: Tonix Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module